statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent...

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City PR Newswire SAN DIEGO, April 11, 2024 SAN DIEGO...

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City

Congress Park Capital LLC increased its position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 205.3% during the fourth quarter, according to its most recent filing with the...

Congress Park Capital LLC Purchases 1,209,500 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)

Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report)'s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.73 and traded...

Heron Therapeutics (NASDAQ:HRTX) Shares Cross Above 200 Day Moving Average of $1.73

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference...

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Heron Therapeutics (HRTX) has issued an update. Ira Duarte has been appointed as the new principal accounting officer of Heron Therapeutics, Inc...

Heron Therapeutics Announces New Principal Accounting Officer

Heron Therapeutics (NASDAQ:HRTX  Get Free Report) had its target price raised by equities research analysts at Needham & Company LLC from $4.00 to $5.00 in a report issued on Wednesday...

Needham & Company LLC Increases Heron Therapeutics (NASDAQ:HRTX) Price Target to $5.00

This price move could indicate a change in the trend, and may be a buy signal for investors...

Heron Therapeutics (HRTX, $3.01) price moved above its 50-day Moving Average on March 13, 2024

HRTX's total volume now sits at 17.8M. The +27.27% price change was insignificant, leaving IBM's price at $3.01...

The volume for Heron Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 308% of the 65-Day Volume Moving Average

This indicator may be signaling HRTX's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Heron Therapeutics (HRTX, $3.01) entered Uptrend as Momentum indicator ascends above 0 level on Mar 13, 2024

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Watchers	7,205
52-Wk Low	$0.50
52-Wk High	$3.22

Volume	3.89M
52-Wk High	$3.22
52-Wk Low	$0.50

HRTX Heron Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community